[New Swiss recommendations for adult boosters against pertussis, tetanus and diphtheria]

C-A Siegrist1

  • 1Centre de vaccinologie, Faculté de médecine et HUG, CMU, 1211 Genève 4. Claire-Anne.Siegrist@unige.ch

Revue Medicale Suisse
|November 29, 2012
PubMed

Insights

Pertussis remains a significant public health concern in Switzerland. The updated immunization plan recommends diphtheria-tetanus-pertussis (dTpa) boosters for adults to protect infants and reduce pertussis transmission.

Area of Science:

  • Public Health
  • Immunology
  • Epidemiology

Context:

  • Pertussis (whooping cough) remains highly prevalent in Switzerland, with approximately 4000 cases annually.
  • Infants are particularly vulnerable, with 80% contracting the disease from family members.
  • Existing immunization schedules require review to optimize protection against preventable diseases.

Purpose:

  • To revise and optimize the Swiss immunization schedule for diphtheria, tetanus, and pertussis (dTpa).
  • To enhance protection for infants and adults against pertussis transmission within family and social networks.
  • To align vaccination recommendations with current epidemiological evidence and reduce unnecessary immunizations.

Summary:

  • The updated Swiss immunization plan recommends a diphtheria-tetanus-pertussis (dTpa) booster at age 25 (catch-up 26-29 years) and for adults in contact with infants under six months.
  • Diphtheria-tetanus (dT) boosters are recommended every 20 years (at ages 25, 45, and 65), with a 10-year interval after age 65.
  • This revised schedule aims to improve pertussis control and prevent infant infections, while optimizing tetanus and diphtheria booster intervals.

Impact:

  • Reduced incidence of pertussis, particularly among vulnerable infant populations.
  • Improved herd immunity and decreased disease transmission within communities.
  • More efficient and evidence-based vaccination strategies, potentially increasing vaccine uptake and adherence.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...